drug addicts, and died at home. Typically, the deceased took several different (prescribed and non-prescribed) drugs with ecstasy; the large number of people who also took opiates seems surprising but confirms previous findings and may explain why a high proportion of the victims were known to services. 4 People may have taken ecstasy with other drugs to modulate the effects-ecstasy had, at least, a facilitating role in causing death. A small proportion of people (6/81; 7%) died after taking only ecstasy-a previously doubted possibility. 5 Toxicological tests could detect all drugs that had been taken in the 2-3 days before death and gave only limited information about which drugs had been taken on the last occasion. Deaths related to ecstasy occurred in two clusters (urban industrial areas in southeast and northern England); people died mostly at party times (weekends, summer, and at New Year).
Information about the incidence of taking ecstasy and other drugs and amounts taken is unfortunately lacking; the database of the National Programme on Substance Abuse Deaths (which is being extended to Northern Ireland and Scotland) will collect more information in future-for example, the concentration of individual drugs in tissues-to obtain a better understanding of the role of other drugs in deaths related to taking ecstasy. 
(Accepted 21 June 2002)
Recent changes in lung cancer incidence for south Asians: a population based register study
In Britain the incidence of lung cancer among south Asians (Indian, Pakistani, and Bangladeshi) is much lower than in the rest of the population. 1 In the UK south Asian population, however, it is the commonest cancer for men and the second commonest for women.
2 Little has been reported on lung cancer trends among south Asians in Britain. We explored trends in lung cancer incidence from 1990 to 1999 in Leicester (22% of residents classified as south Asian in 1991 census).
Participants, methods, and results
We identified cases of lung cancer diagnosed in Leicester residents between 1 January 1990 and 31 December 1999 from the Trent Cancer Registry. Ethnicity data were not available for all patients, so we used software assessing forename and surname to classify patients as south Asian or non-south Asian, 3 with visual inspection of the data to increase accuracy. We assessed deprivation using the Townsend index. The local research ethics committee approved the study.
Population estimates at the level of electoral wards from the 1991 census (categorised by sex, ethnicity, and 5 year age bands) were aggregated by deprivation tertile to calculate lung cancer incidence. We investigated variation in incidence by ethnicity, deprivation, age, and year of diagnosis and any interactions between them using Poisson regression separately for men and women. We calculated the interaction between period of diagnosis (1990-4 or 1995-9 ) and ethnicity to compare trends over time.
Of the 1902 patients with lung cancer identified, 76 were classified as south Asian (4%). South Asians were slightly younger than non-south Asians (median age 70.3 v 72.1 years). After adjusting for differences in age and deprivation, we found lung cancer rates were lower for south Asians than non-south Asians (incidence ratio for men 0.41 (95% confidence interval 0.31 to 0.54), for women 0.32 (0.20 to 0.50)).
The adjusted incidence increased over time for south Asian men but decreased for non-south Asian men (P=0.038), with an increase in risk of 43% for south Asian men (incidence ratio for 1990-4 v 1995-9 1.43 (0.84 to 2.44)) and a decrease of 19% for non-south Asian men (0.81 (0.72 to 0.91)). For non-south Asian men, the decrease in incidence occurred in those from more deprived areas, where lung cancer incidence was higher (see figure) . There was no evidence of a trend with deprivation over time for south Asian men.
Patterns for women were different, with slight increases in lung cancer incidence over time for both south Asians and non-south Asians and no evidence of differing patterns over time (P=0.489). South Asian women had a 50% increase in risk (1.50 (0.61 to 3.67)), while the increase in risk for non-south Asians was 9% (1.09 (0.93 to 1.28)). The changes in incidence over time were similar for all levels of deprivation (see figure) . 
Comment
Our findings confirm lower rates of lung cancer for south Asian men than non-south Asian men but suggest differing trends, with incidence increasing among south Asian men but falling among non-south Asians. There is a tendency to emphasise the importance of cancers such as those of the head and neck among south Asians because they are relatively more common than in the majority UK population. However, Bhopal and Rankin also highlight the need to look at absolute numbers of cancer cases, 2 which show that lung cancer is the commonest cancer for both south Asian and non-south Asian men. With smoking rates higher among UK south Asians aged 30-49 years than those aged 50-74, 4 lung cancer prevention is a high priority. Health promotion programmes should target the whole population, and the tendency to dismiss south Asians as "low risk" populations for smoking related disease needs to be revised.
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Platelet responsiveness to aspirin in patients with hyperlipidaemia
Maribeth Friend, Ivana Vucenik, Michael Miller
Aspirin 325 mg/day reduces the rate of events associated with coronary heart disease. In most people, aspirin produces irreversible inhibition of platelet aggregation, but in a sizeable minority of patients, the degree of platelet aggregation needed to prevent events according to in vitro assessments is not achieved. 1 Risk factors for coronary heart disease may contribute to aspirin resistance (the inability of aspirin to protect individuals from thrombotic complications), so aspirin may not be cardioprotective in patients with hyperlipidaemia. 2 We evaluated patients with a range of cholesterol concentrations to determine the impact of hypercholesterolaemia on platelet responsiveness in patients treated with aspirin.
Participants, methods, and results
Consecutive patients (n=56) were recruited from the University of Maryland Preventive Cardiology Outpatient Center. The mean (SD) age was 54.3 (11.1) Incidence ratios (95% confidence intervals) of lung cancer comparing incidence for 1995-9 with that for 1990-4 among south Asian and non-south Asian men and women by deprivation tertile (1=least deprived, 3=most deprived 
